Computerized Surveillance of Adverse Drug Events in Hospital Patients

JAMA: The Journal of the American Medical Association

Volumn 266, Issue 20, 1991, Pages 2847-2851

  Classen, David C ^a,b   Pestotnik, Stanley L ^a,b   Evans, R Scott ^a,b   Burke, John P ^a,b  

^a LDS HOSPITAL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; DIURETIC AGENT; IMMUNOSUPPRESSIVE AGENT; MORPHINE; NALOXONE; PARACETAMOL; PETHIDINE;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CHILD; COMPUTER PROGRAM; HOSPITAL; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; PRIORITY JOURNAL; THROMBOCYTOPENIA; UNITED STATES;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CAUSALITY; CHILD; DRUG MONITORING; DRUG THERAPY; FEMALE; HEALTH CARE COSTS; HOSPITAL BED CAPACITY, 500 AND OVER; HOSPITAL INFORMATION SYSTEMS; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGE; PROSPECTIVE STUDIES; SUPPORT, U.S. GOV'T, P.H.S.; UTAH;

EID: 0025719244     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1991.03470200059035     Document Type: Article

References (40)

1. Jick H. Drugs: remarkably non-toxic. N Engl J Med. 1974;291:824-828.
2. Miller RR. Interpretation of studies on adverse drug reactions. Am J Hosp Pharm. 1977;34:753-754.
3. Talley RB, Laventurier MF. Drug-induced illness. JAMA. 1974;229:1043.
4. Porter J, Jick H. Drug-related deaths among medical inpatients. JAMA. 1977;237:879-881.
5. Caranasos GJ, Stewart RB, Cluff LE. Drug-induced illness leading to hospitalization. JAMA. 1974;228:713-717.
6. Miller RR. Hospital admissions due to adverse drug reactions: a report from the Boston Collaborative Drug Surveillance Program. Arch Intern Med. 1974;134:219-223.
7. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324:377-384.
8. Melmon KL. Preventable drug reactions: causes and cures. N Engl J Med. 1971;284:1361-1368.
9. Seidl LG, Thornton GF, Smith JW, et al. Studies on the epidemiology of adverse drug reactions, III: reactions in patients on a general medical service. Bull Johns Hopkins Hosp. 1966;119:299-315.
10. Karch FE, Lasagna L. Adverse drug reactions: a critical review. JAMA. 1975;234:1236-1241.
11. Cluff LE, Caranasos GJ, Stewart RB. Clinical problems with drugs. In: Smith LH, ed. Major Problems in Internal Medicine. Philadelphia, Pa: WB Saunders Co; 1975;5.
12. International drug monitoring: the role of the hospital. WHO Tech Rep Ser. 1969;426:5-24.
13. Pearson KC, Kennedy DL. Adverse drug reactions and the Food and Drug Administration. J Pharm Pract. 1989;2:209-213.
14. Joint Commission on Accreditation of Healthcare Organizations. Accreditation Manual for Hospitals, 1991. Chicago, Ill: Joint Commission on Accreditation of Healthcare Organizations; 1991.
15. Sanazaro PJ, Mills DH. A critique of the use of generic screening in quality assessment. JAMA. 1991;265:1977-1981.
16. Bennett BS, Lipman AG. Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions. Am J Hosp Pharm. 1977;34:931-936.
17. Edlavitch SA. Adverse drug event reporting: improving the low US reporting rate. Arch Intern Med. 1988;148:1499-1503.
18. Pryor TA, Gardner RM, Clayton PD, Warner HR. The HELP system. J Med Sys. 1983;7:87-102.
19. Classen DC, Burke JP, Pestotnik SL, Evans RS, Stevens LE. Surveillance for quality assessment, IV: surveillance using a hospital information system. Infect Control Hosp Epidemiol. 1991;12:239-244.
20. World Health Organization. Collaborating Centers for International Drug Monitoring. Geneva, Switzerland: World Health Organization; 1984. WHO publication DEM/NC/84.153 (E).
21. Classen DC, Pestotnik SL, Evans RS, Bass S, Burke JP. Concurrent monitoring of adverse drug events through the use of a hospital information system. Presented at the Sixth International Conference on Pharmacoepidemiology; August 11, 1990; Anaheim, Calif.
22. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
23. Michel DJ, Knodel LC. Comparison of three algorithms used to evaluate adverse drug reactions. Am J Hosp Pharm. 1986;43:1709-1714.
24. Rawlins MD. Clinical pharmacology: adverse reactions to drugs. BMJ. 1981;282:974-976.
25. Ouslander JG. Drug therapy in the elderly. Ann Intern Med. 1981;95:711-722.
26. Steel K, Gertman PM, Crescenzi C, Anderson J. Iatrogenic illness on a general medical service at a university hospital. N Engl J Med. 1988;304:638-642.
27. Salazar TA. End-organ toxicities of adverse drug reactions. J Pharm Prac. 1989;2:245-250.
28. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med. 1991;114:956-966.
29. Jick H. Adverse drug reactions: the magnitude of the problem. J Allergy Clin Immunol. 1984;74:555-557.
30. Miller RR. Drug surveillance utilizing epidemiologic methods: a report from the Boston Collaborative Drug Surveillance Program. Am J Hosp Pharm. 1973;30:584-592.
31. Rossi AC, Bosco L, Faich GA, Tanner A, Temple R. The importance of adverse reaction reporting by physicians: suprofen and the flank pain syndrome. JAMA. 1988;259:1203-1204.
32. Berry LL, Segal R, Sherrin TP, Fudge KA. Sensitivity and specificity of three methods of detecting adverse drug reactions. Am J Hosp Pharm. 1988;45:1534-1539.
33. Jacinto MS, Kleinmann K. Hospital pharmacy program for reporting adverse drug reactions. Am J Hosp Pharm. 1983;40:444-445.
34. Nelson RW, Shane R. Developing an adverse drug reaction reporting program. Am J Hosp Pharm. 1983;40:445-446.
35. Miwa LJ. Implementing a hospital-based adverse drug reaction reporting program. J Pharm Pract. 1989;2:214-220.
36. Rogers AS, Israel E, Smith CR, et al. Physician knowledge, attitudes, and behavior related to reporting adverse drug events. Arch Intern Med. 1988;148:1596-1600.
37. McCollam A, Thornton J, Kasuya A. Development of an adverse drug reaction reporting system. Infusion. 1989;12:3-6.
38. Tatro DS, Moore TN, Cohen SN. Computer-based system for adverse drug reaction detection and prevention. Am J Hosp Pharm. 1979;36:198-201.
39. Maliekal J, Thornton J. A description of a successful computerized adverse drug reaction tracking program. Hosp Formul. 1990;25:436-442.
40. Shapiro S, Slone D, Lewis GP, et al. Fatal drug reactions among medical inpatients. JAMA. 1971;216:467-472.